Business Context and Reporting Period
Company: ANAVEX LIFE SCIENCES CORP.
Filing Type: Form 8-K (Current Report)
Report Date: March 30, 2011
Event: Entry into a Material Definitive Agreement (Item 1.01) and Unregistered Sales of Equity Securities (Item 3.02).
Key Financial Metrics
This filing does not contain audited financial statements, revenue, profit, cash flow, or debt metrics. The only financial terms disclosed relate to a specific consulting agreement:
- Consulting Fee: $500 per hour, capped at five hours per month.
- Equity Compensation: Issuance of 100,000 share purchase options.
- Option Exercise Price: $3.67 per share.
- Option Term: Five years.
- Expenses: Reimbursement of pre-approved and certain travel expenses.
Material Changes
The filing reports the execution of a one-year consulting agreement with Shackleton Consulting Corp. to advise on business opportunities and strategic development. This agreement involves the issuance of unregistered equity securities (options) to a non-U.S. person under Regulation S and Section 4(2) exemptions. No prior period comparison data is provided in this document.
Guidance, Outlook, and Risks
Management Commentary: The company engaged an advisor to identify business opportunities and strategic development.
Contract Terms: The agreement is for one year unless extended and may be terminated by either party with one month's written notice.
Risks/Contingencies: The filing notes the issuance of securities in an offshore transaction relying on registration exemptions. No specific financial risks or forward-looking guidance regarding revenue or operations are detailed in this report.
Investor Verification Checklist
- Verify the current market price of ANAVEX shares relative to the $3.67 option exercise price.
- Confirm the total potential dilution impact of the 100,000 options issued.
- Review the attached Exhibit 10.1 (Consulting Agreement) for specific deliverables and termination clauses.
- Check subsequent filings for updates on the strategic opportunities identified by the advisor.